
Cooper Companies (COO) Stock Forecast & Price Target
Cooper Companies (COO) Analyst Ratings
Bulls say
CooperCompanies demonstrated strong financial performance with an increase in operating margin, which rose 120 basis points year-over-year to 27.0%, surpassing consensus estimates. The company expects free cash flow for FY26 to reach between $575 million and $625 million, indicating a significant year-over-year growth of 33-44%. Additionally, the Paragard product line experienced a 16% increase in revenue year-over-year, contributing to an optimistic outlook for future growth despite challenges in gross margins due to tariffs and product mix.
Bears say
Cooper Companies is experiencing a negative outlook due to several fundamental challenges reflected in its financial performance and market conditions. The company's expected organic revenue growth has been revised down to 4.9% for FY26, influenced by ongoing pricing pressures from e-commerce competitors in the Asia-Pacific region and a notable 28% decline in sales in China, primarily within the contact lens segment. Additionally, the gross margin of 66.2% fell short of expectations, driven by tariffs and product mix issues, while the Fertility segment has shown a significant slowdown in sales growth, exiting FY25 at just 1%, far below its historical growth rate.
This aggregate rating is based on analysts' research of Cooper Companies and is not a guaranteed prediction by Public.com or investment advice.
Cooper Companies (COO) Analyst Forecast & Price Prediction
Start investing in Cooper Companies (COO)
Order type
Buy in
Order amount
Est. shares
0 shares